JCOG: The Japan Clinical Oncology Group
JCOG: The Japan Clinical Oncology Group
Immunotherapy and targeted agents for elderly lung cancer patients
PARP inhibitors in metastatic breast cancer: The present and the future
Treatment pathways for patients with triple-negative breast cancer
The challenge of detecting NTRK fusions across tumour types
The latest research highlights in lymphoma
GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanced head and neck squamous cell carcinoma
Shaping the future of metastasis - ecancer investigates
Comment: Critical quality attributes of biosimilars
Comment: Use of biosimilar monoclonal antibodies in the clinic
Comment: Supporting a sustainable biosimilar solution
Realising the potential of biosimilars